← Leaderboards
Patrick J Hayden
Mattek Corporation
$7,447,510
Attributed
$8,074,309
Total exposure
15
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,074,309 · 15
By mechanism
R44$4,341,935 · 4
R43$1,986,883 · 9
U44$961,992 · 1
U01$783,499 · 1
Top collaborators
- Steven M. Dubinett1 shared
- David Elashoff1 shared
- Marc Elliott Lenburg1 shared
- Avrum E Spira1 shared
Most similar at Mattek Corporation
Same institution · by research overlap
- Seyoum Ayehunie$12,970,385
- Yulia Kaluzhny$2,670,406
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroSkinResponseProductionBiological ModelsModel Design /DevelopmentValidationConsumer ProductTissue /Cell CultureKeratinocyteLaboratoriesAnimalsCellsTechnologyIn VivoProtocols DocumentationToxic EffectEpithelial CellsIndustryContractsIn Vitro ModelTissuesBreathingReporting
Grant awards (21)
Development of Cell Culture Inserts and 3D In Vitro Tissue Models Utilizing Novel Electrospun Scaffolds$840,696
R44 · FY2024 · ES · contact PI
Development of Cell Culture Inserts and 3D In Vitro Tissue Models Utilizing Novel Electrospun Scaffolds$884,718
R44 · FY2023 · ES · contact PI
Implantable Electrospun Cell Chamber Device with Immune-Evasive Properties for Beta Cell Replacement Therapy$275,766
R43 · FY2023 · DK · contact PI
Validation of an In Vitro Human Airway Model for Regulatory Toxicity Testing$530,965
U44 · FY2018 · ES · contact PI
Validation of an In Vitro Human Airway Model for Regulatory Toxicity Testing$431,027
U44 · FY2017 · ES · contact PI
Genetically modified tissue engineered in vitro human models$483,227
R44 · FY2013 · GM · contact PI
The UCLA - Boston University Lung Cancer Biomarker Development Laboratory$783,499
U01 · FY2012 · CA
Validation of an In Vitro Human Airway Model$537,491
R44 · FY2012 · ES · contact PI
Genetically modified tissue engineered in vitro human models$483,227
R44 · FY2012 · GM · contact PI
Validation of an In Vitro Human Airway Model$298,491
R44 · FY2011 · ES · contact PI
Genetically modifed tissue engineered in vitro human models$221,236
R43 · FY2009 · GM · contact PI
Globally Harmonized In Vitro Skin Irritation Assay$255,954
R43 · FY2008 · AR · contact PI
Tissue Engineered In Vitro Human Airway Models of Asthma and COPD$215,533
R43 · FY2007 · HL · contact PI
Validation of an In Vitro Human Airway Model$199,903
R43 · FY2005 · ES
In Vitro Model of the Human Alveolar Epithelium$249,404
R43 · FY2004 · CA
In Vitro Culture Model of the Human Blood-Brain Barrier$124,965
R43 · FY2004 · CA
In Vitro Culture Model of the Human Blood-Brain Barrier$244,122
R43 · FY2003 · CA
High-Throughput Screening of Therapeutics$476,109
R44 · FY2002 · ES
High-Throughput Screening of Therapeutics$337,976
R44 · FY2001 · ES
IN VITRO MODEL FOR MEASURING SUNSCREEN PROTECTION$100,000
R43 · FY2001 · AR
HIGH-THROUGHPUT SCREEN OF TOPICALLY APPLIED THERAPEUTICS$100,000
R43 · FY2000 · ES